Abstract
Psychiatrists’ decision making about prescribing benzodiazepines (BZD) was evaluated in a community mental health center. An anonymous survey of outpatient psychiatrists in an academic-affiliated public mental health center was conducted using a 45-item questionnaire developed based on the results of a previous study. Sixty-six percent of responses indicate that, at times, psychiatrists experienced requests for behaviors suspicious for abuse, including ‘lost/missing prescriptions’ and ‘use of BZD by others’. Patient characteristics such as ‘history of abuse’, ‘unknown patient’, and ‘patient use of illicit substances’ were occasional or common reasons for NOT prescribing BZDs (75 %). The most common contexts in which the majority of our sample was uncomfortable prescribing BZDs involved a patient history of substance abuse, fear of initiation of dependence, diversion, and feeling manipulated by the patient. Time limitations were a dilemma for 20 %. Psychiatrist self-reported dilemma and behavior in prescribing BZDs largely reflected concerns with substance abuse and less frequently workload or time issues.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Merikangas KR, Mehta RL, Molnar BE, et al.: Comorbidity of substance use disorders with mood and anxiety disorders: Results of the international consortium in psychiatric epidemiology. Addictive Behaviors 23(6):893–907, 1998
Kessler RC, Nelson CB, McGonagle KA, et al.: The epidemiology of co-occurring addictive and mental disorders: Implications for prevention and service utilization. American Journal of Orthopsychiatry 66(1):17–31, 1996
Warneke LB: Benzodiazepines: Abuse and new use. Canadian Journal of Psychiatry 36(3):194–205, 1991
Lader M: Effectiveness of benzodiazepines: Do they work or not? Expert Review of Neurotherapeutics 8(8):1189–91, 2008
Beland SG, Preville M, Dubois MF, et al.: Benzodiazepine use and quality of sleep in the community-dwelling elderly population. Aging & Mental Health 14(7):843–50, 2010
Brunette MF, Noordsy DL, Xie H, et al.: Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders. Psychiatric Services 54(10):1395–401, 2003
Cloos JM, Ferreira V: Current use of benzodiazepines in anxiety disorders. Current Opinion in Psychiatry 22(1):90–5, 2009
Zaider TI, Heimberg RG: Non-pharmacologic treatments for social anxiety disorder. Acta Psychiatrica Scandinavica Supplementum (417):72–84, 2003
Olatunji BO, Cisler JM, Deacon BJ: Efficacy of cognitive behavioral therapy for anxiety disorders: A review of meta-analytic findings. Psychiatric Clinics of North America 33(3):557–77, 2010
Haw C, Stubbs J: Benzodiazepines: A necessary evil? A survey of prescribing at a specialist UK psychiatric hospital. Journal of Psychopharmacology 21(6):645–9, 2007
Ravindran LN, Stein MB: The pharmacologic treatment of anxiety disorders: A review of progress. Journal of Clinical Psychiatry 71(7):839–54, 2010
Posternak MA, Mueller TI: Assessing the risks and benefits of benzodiazepines for anxiety disorders in patients with a history of substance abuse or dependence. American Journal on Addictions 10(1):48–68, 2001
Rosenbaum JF: Attitudes toward benzodiazepines over the years. Journal of Clinical Psychiatry 66 Suppl 2(4):4–8, 2005
Clark RE, Xie H, Brunette MF: Benzodiazepine prescription practices and substance abuse in persons with severe mental illness. Journal of Clinical Psychiatry 65(2):151–5, 2004
Bendtsen P, Hensing G, McKenzie L, et al.: Prescribing benzodiazepines: A critical incident study of a physician dilemma. Social Science & Medicine 49(4):459–67, 1999
Fischer B, Bibby M, Bouchard M: The global diversion of pharmaceutical drugs non-medical use and diversion of psychotropic prescription drugs in North America: A review of sourcing routes and control measures. Addiction 105(12):2062–70, 2010
Straand J, Rokstad K: General practitioners’ prescribing patterns of benzodiazepine hypnotics: Are elderly patients at particular risk for overprescribing? A report from the Møre & Romsdal Prescription Study. Scandinavian Journal of Primary Health Care 15(1):16–21, 1997
Cook JM, Marshall R, Masci C, et al.: Physicians’ perspectives on prescribing benzodiazepines for older adults: A qualitative study. Journal of General Internal Medicine 22(3):303–7, 2007
Parr JM, Kavanagh DJ, Cahill L, et al.: Effectiveness of current treatment approaches for benzodiazepine discontinuation: A meta-analysis. Addiction 104(1):13–24, 2009
de las Cuevas C, Sanz EJ: Controversial issues associated with the prescription of benzodiazepines by general practitioners and psychiatrists. Medical Science Monitor 10(7):CR288–93, 2004
Siriwardena AN, Qureshi Z, Gibson S, et al.: GPs’ attitudes to benzodiazepine and ‘Z-drug’ prescribing: A barrier to implementation of evidence and guidance on hypnotics. British Journal of General Practice 56(533):964–7, 2006
Rogers A, Pilgrim D, Brennan S, et al.: Prescribing benzodiazepines in general practice: A new view of an old problem. Health (London) 11(2):181–98, 2007
Hamilton IJ, Reay LM, Sullivan FM: A survey of general practitioners’ attitudes to benzodiazepine overprescribing. Health Bull (Edinb) 48(6):299–303, 1990
Parr JM, Kavanagh DJ, Young RM, et al.: Views of general practitioners and benzodiazepine users on benzodiazepines: A qualitative analysis. Social Science & Medicine 62(5):1237–49, 2006
Lader M, Tylee A, Donoghue J: Withdrawing benzodiazepines in primary care. CNS Drugs 23(1):19–34, 2009
Cook JM, Biyanova T, Masci C, et al.: Older patient perspectives on long-term anxiolytic benzodiazepine use and discontinuation: A qualitative study. Journal of General Internal Medicine 22(8):1094–100, 2007
Barter G, Cormack M: The long-term use of benzodiazepines: Patients’ views, accounts and experiences. Family Practise 13(6):491–7, 1996
Iliffe S, Curran HV, Collins R, et al.: Attitudes to long-term use of benzodiazepine hypnotics by older people in general practice: Findings from interviews with service users and providers. Aging & Mental Health 8(3):242–8, 2004
Author information
Authors and Affiliations
Corresponding author
Additional information
The information in this paper has not been presented or published elsewhere. However, an abstract with most of the data was presented at the conference of the College on Problems of Drug Dependence.
Rights and permissions
About this article
Cite this article
Marienfeld, C.B., Tek, E., Diaz, E. et al. Psychiatrist Decision-Making Towards Prescribing Benzodiazepines: The Dilemma with Substance Abusers. Psychiatr Q 83, 521–529 (2012). https://doi.org/10.1007/s11126-012-9220-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11126-012-9220-8